Head and Neck network
Head and neck cancer (HNC) is the 6th most incident cancer worldwide: in Sweden approx. 1,600 patients per year present with the disease. It involves malignancies localised to the sinonasal and oral cavities, the pharynx, the larynx, and the salivary glands. Conventionally, treatments include surgery and radio¬therapy (w/wo chemotherapy). The recent introduction of immunotherapy, notably immune ch
https://www.lucc.lu.se/internal/research/strategic-networks/head-and-neck-network - 2026-06-09
